Evidence map›Paper›PMID 32870122›Full record

Trial reportSubstance abuse2021

Impact of extended release naltrexone on health-related quality of life in individuals with legal involvement and opioid use disorders.

Ekaterina Pivovarova, Hye Sung Min, Peter D Friedmann

Open access · bronzeAbstract readMulticenter StudyRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Substance abuse, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Sustained-release naltrexone for opioid dependence.The Cochrane database of systematic reviews · 2025
    Pooled it
  2. Trial
  3. Quality of life measures in treatment for active substance misuse: a scoping review.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2025
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Ekaterina PivovarovaDepartment of Family Medicine & Community Health and Department of Psychiatry, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Hye Sung MinDepartment of Population Health and Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Peter D FriedmannDepartment of Population Health and Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
University of Massachusetts Chan Medical School · USBaystate Health · US

Funding

Treatment Study Using Depot Naltrexone(2/6)Rhode Island Protocol Treatment SiteR01DA024549 · NIDA · RHODE ISLAND HOSPITAL · PI FRIEDMANN, PETER D · 2008 to 2014
$1.9M
Increasing Referrals to Medications for Opioid Use Disorders from Drug Treatment Courts using Organizational Linkage InterventionK23DA049953 · NIDA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI PIVOVAROVA, EKATERINA · 2020 to 2022
$612k
NIDA NIH HHS K23 DA049953NIDA NIH HHS L30 DA046885NIDA NIH HHS R01 DA024549
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Opioid-Related DisordersQuality of LifeAdultDelayed-Action PreparationsHumansInjections, IntramuscularNaltrexoneNarcotic AntagonistsDelayed-Action PreparationsNaltrexoneNarcotic Antagonistscriminal justiceextended release naltrexonemedication assisted treatmentmedication for opioid use disorderOpioid use disorderquality of life

Identifiers

PMID32870122
PMCPMC9100853
OpenAlexW3082926874

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.